The former (IMPDH1) is a known target in cancer therapy that might made DHZ as a potential chemoprotective compound, while the latter (SPSB2) has an antiviral role, leading tZOG to hypothetically be an antiviral compound. This evidence concerns the gene IMPDH1 and cancer.